Rock Springs Capital Management
$1.7B Assets Reported
106 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 1,209,465 | $118M | 6.9% |
| LLY | ELI LILLY & CO | 98,700 | $91M | 5.4% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 170,999 | $90M | 5.3% |
| MIRM | MIRUM PHARMACEUTICALS INC | 811,294 | $75M | 4.4% |
| ARGX | ARGENX SE | 98,500 | $72M | 4.2% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 689,748 | $60M | 3.5% |
| INSM | INSMED INC | 314,300 | $51M | 3.0% |
| ASND | ASCENDIS PHARMA A/S | 194,000 | $44M | 2.6% |
| XENE | XENON PHARMACEUTICALS INC | 763,020 | $44M | 2.6% |
| TVTX | TRAVERE THERAPEUTICS INC | 1,477,954 | $44M | 2.6% |
Track Rock Springs Capital Management's 13F portfolio: $1.7B in reported holdings, 106 positions. Top holdings, AUM, and quarterly changes on SentiSense.